A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT03164915 · COMPLETED
Trial details
- NCT number
- NCT03164915
- Sponsor
- SK Plasma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-24
- Primary completion
- 2018-04-03
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.